1. Home
  2. NVEE vs ATRC Comparison

NVEE vs ATRC Comparison

Compare NVEE & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVEE
  • ATRC
  • Stock Information
  • Founded
  • NVEE 1949
  • ATRC 2000
  • Country
  • NVEE United States
  • ATRC United States
  • Employees
  • NVEE N/A
  • ATRC N/A
  • Industry
  • NVEE Other Consumer Services
  • ATRC Medical/Dental Instruments
  • Sector
  • NVEE Consumer Discretionary
  • ATRC Health Care
  • Exchange
  • NVEE Nasdaq
  • ATRC Nasdaq
  • Market Cap
  • NVEE 1.5B
  • ATRC 1.7B
  • IPO Year
  • NVEE 2013
  • ATRC 2005
  • Fundamental
  • Price
  • NVEE $22.83
  • ATRC $32.28
  • Analyst Decision
  • NVEE Buy
  • ATRC Strong Buy
  • Analyst Count
  • NVEE 4
  • ATRC 10
  • Target Price
  • NVEE $25.67
  • ATRC $49.60
  • AVG Volume (30 Days)
  • NVEE 816.9K
  • ATRC 469.5K
  • Earning Date
  • NVEE 08-06-2025
  • ATRC 07-29-2025
  • Dividend Yield
  • NVEE N/A
  • ATRC N/A
  • EPS Growth
  • NVEE N/A
  • ATRC N/A
  • EPS
  • NVEE 0.45
  • ATRC N/A
  • Revenue
  • NVEE $962,752,000.00
  • ATRC $480,076,000.00
  • Revenue This Year
  • NVEE $11.23
  • ATRC $14.63
  • Revenue Next Year
  • NVEE $5.16
  • ATRC $12.62
  • P/E Ratio
  • NVEE $50.94
  • ATRC N/A
  • Revenue Growth
  • NVEE 8.74
  • ATRC 15.79
  • 52 Week Low
  • NVEE $14.75
  • ATRC $20.20
  • 52 Week High
  • NVEE $26.14
  • ATRC $43.11
  • Technical
  • Relative Strength Index (RSI)
  • NVEE 63.81
  • ATRC 47.04
  • Support Level
  • NVEE $22.47
  • ATRC $30.98
  • Resistance Level
  • NVEE $22.86
  • ATRC $33.00
  • Average True Range (ATR)
  • NVEE 0.33
  • ATRC 1.12
  • MACD
  • NVEE -0.15
  • ATRC -0.08
  • Stochastic Oscillator
  • NVEE 61.70
  • ATRC 30.52

About NVEE NV5 Global Inc.

NV5 Global Inc is a provider of technology, conformity assessment, and consulting solutions to public and private sector clients in the infrastructure, utility services, construction, real estate, environmental, and geospatial markets, operating nationwide and abroad. The Company's clients include the U.S. Federal, state and local governments, and the private sector. It also serve quasi-public and private sector clients from the education, healthcare, utility services, and public utilities, including schools, universities, hospitals, health care providers, and insurance providers. The operating business segments are Infrastructure, Building, Technology & Sciences, and Geospatial Solutions. The maximum revenue derives from the infrastructure segment.

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

Share on Social Networks: